SynGenSys unveils NK.SET synthetic promoter library for natural killer cell therapies
SynGenSys has introduced NK.SET™, the first commercially available synthetic promoter library designed specifically for natural killer (NK) cell immunotherapies. The Sheffield-based biotechnology company’s announce-ment marks a significant validation of its platform for engineering tissue-specific gene regulation control elements.


